Author

Mariam Eldebeiky

Observed names: Eldebeiky, Mariam, M Eldebeiky, M. Eldebeiky

Institution: Egyptian Government

Observed institution: Egyptian Government

OpenAlex ID: A5085643892

A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt

2022 · Baher Elezbawy, Ahmad Nader Fasseeh, et al. · Journal of Pharmaceutical Policy and Practice · 19

PDF

Framework for developing cost-effectiveness analysis threshold: the case of Egypt

2024 · Ahmad N. Fasseeh, Nada Korra, et al. · Journal of the Egyptian Public Health Association · 17

A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt

2022 · Baher Elezbawy, Ahmad Nader Fasseeh, et al. · BMC Medical Informatics and Decision Making · 16

PDF

Institutionalizing health technology assessment in Egypt: Situational analysis and roadmap

2022 · Pilar Pinilla-Dominguez, Shorouk Taha, et al. · Frontiers in Pharmacology · 14

PDF

Maximizing the benefits of using biosimilars in Egypt

2023 · Ahmad Nader Fasseeh, Baher Elezbawy, et al. · Journal of Pharmaceutical Policy and Practice · 10

PDF

National Recommendations for Pharmacoeconomic Evaluations Reporting for Reimbursement and Procurement of New Pharmaceutical Applications in Egypt

2024 · Mary Gamal, Amal Samir Sedrak, et al. · Global Journal on Quality and Safety in Healthcare · 6

HPR180 Eligibility of Orphan Drugs for Preferential Reimbursement in Egypt

2022 · AN Fasseeh, B Elezbawy, et al. · Value in Health · 4

POSB205 Framework for Implementing Cost-Effectiveness Thresholds in Egypt

2022 · AN Fasseeh, B Elezbawy, et al. · Value in Health · 4

Correction: Framework for developing cost-effectiveness analysis threshold: the case of Egypt

2024 · Ahmad N. Fasseeh, Nada Korra, et al. · Journal of the Egyptian Public Health Association · 1

PDF

POSB253 Development of a Multi Criteria Decision Analysis (MCDA) Tool for Medical Devices National Procurement in Egypt

2022 · AN Fasseeh, B Elezbawy, et al. · Value in Health · 1

Developing a Multicriteria Decision Analysis Framework to Establish Differential Cost-Effectiveness Thresholds for Orphan Drugs in Egypt

2026 · Ahmad Nader Fasseeh, Baher Elezbawy, et al. · Bulletin of Faculty of Pharmacy Cairo University

PDF

HTA375 Strengthening Value-Based Assessment Systems for Enhanced Patient Access to Health Technologies in the Future Universal Health Coverage System in Egypt

2024 · M Eldebeiky, A Farag, et al. · Value in Health

HTA341 Egyptian Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Applications

2023 · M. Roushdy, G. Elsisi, et al. · Value in Health

PDF

EE212 Budget Impact Analysis of Adopting Prophylactic Approach in the Management of Hemophilia A in Egypt From Payor Perspective

2022 · I Anan, S Taha, et al. · Value in Health

HTA16 Purchasing Implantable Medical Devices in Egypt Using a Multicriteria Decision Analysis (MCDA) Tool

2022 · B Elezbawy, AN Fasseeh, et al. · Value in Health

PDF

POSA259 A Multi-Criteria Decision Analysis (MCDA) Tool for Purchasing Off-Patent Oncology Drugs in Egypt

2022 · B Elezbawy, AN Fasseeh, et al. · Value in Health

Additional file 3 of A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt

2022 · Elezbawy, Baher, Fasseeh, Ahmad Nader, et al. · Figshare

Works count: 22

Citation count: 92

H-index: 6

I10-index: 5